NEW YORK, Feb 1 – Genome Therapeutics has agreed to sequence the genome of an undisclosed pathogenic organism for Wyeth-Lederle Vaccines, the companies said Thursday.

The name of the pathogen remains confidential under the agreement, and Wyeth-Lederle Research spokesman Doug Petkus would say only that the genome “will be useful for our discovery efforts.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.